Literature DB >> 16695841

THE EFFECT OF CUSHING'S SYNDROME UPON SERUM ALBUMIN METABOLISM.

K Sterling1.   

Abstract

Year:  1960        PMID: 16695841      PMCID: PMC441915          DOI: 10.1172/JCI104214

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  20 in total

1.  The mechanism of hypoproteinemia associated with giant hypertrophy of the gastric mucosa.

Authors:  Y CITRIN; K STERLING; J A HALSTED
Journal:  N Engl J Med       Date:  1957-11-07       Impact factor: 91.245

2.  Studies on the metabolism of plasma proteins in the nephrotic syndrome. I. Albumin, gamma-globulin and iron-binding globulin.

Authors:  D GITLIN; C A JANEWAY; L E FARR
Journal:  J Clin Invest       Date:  1956-01       Impact factor: 14.808

3.  The effect of large doses of desiccated thyroid on the distribution and metabolism of albumin-I 131 in euthyroid subjects.

Authors:  M A ROTHSCHILD; A BAUMAN; R S YALOW; S A BERSON
Journal:  J Clin Invest       Date:  1957-03       Impact factor: 14.808

4.  Studies on Cushing's syndrome. I. Observations on the response of plasma 17-hydroxycorticosteroid levels to corticotropin.

Authors:  N P CHRISTY; D LONGSON; J W JAILER
Journal:  Am J Med       Date:  1957-12       Impact factor: 4.965

5.  The role of I 131 labeled proteins in biology & medicine; concluding remarks.

Authors:  S P MASOUREDIS
Journal:  Ann N Y Acad Sci       Date:  1957-08-30       Impact factor: 5.691

6.  Chemical and biological alterations induced by irradiation of I 131 labeled human serum albumin.

Authors:  S A BERSON; R S YALOW
Journal:  J Clin Invest       Date:  1957-01       Impact factor: 14.808

7.  Distribution and metabolism of I131 labeled human serum albumin in congestive heart failure with and without proteinuria.

Authors:  A BAUMAN; M A ROTHSCHILD; R S YALOW; S A BERSON
Journal:  J Clin Invest       Date:  1955-09       Impact factor: 14.808

8.  Tracer experiments with I131 labeled human serum albumin: distribution and degradation studies.

Authors:  S A BERSON; R S YALOW; S S SCHREIBER; J POST
Journal:  J Clin Invest       Date:  1953-08       Impact factor: 14.808

9.  Nitrogen balance, liver protein repletion and body composition of cortisone treated rats.

Authors:  R H SILBER; C C PORTER
Journal:  Endocrinology       Date:  1953-05       Impact factor: 4.736

10.  The effect of cortisone upon protein synthesis.

Authors:  I CLARK
Journal:  J Biol Chem       Date:  1953-01       Impact factor: 5.157

View more
  8 in total

1.  Studies of I-131-albumin catabolism and distribution in normal young male adults.

Authors:  W L BEEKEN; W VOLWILER; P D GOLDSWORTHY; L E GARBY; W E REYNOLDS; R STOGSDILL; R S STEMLER
Journal:  J Clin Invest       Date:  1962-06       Impact factor: 14.808

Review 2.  Serum albumin.

Authors:  M A Rothschild; M Oratz; S S Schreiber
Journal:  Am J Dig Dis       Date:  1969-10

3.  Augmentation of albumin but not fibrinogen synthesis by corticosteroids in patients with hepatocellular disease.

Authors:  G D Cain; G Mayer; E A Jones
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

4.  Albumin metabolism: effect of the nutritional state and the dietary protein intake.

Authors:  W P James; A M Hay
Journal:  J Clin Invest       Date:  1968-09       Impact factor: 14.808

Review 5.  Review of the toxicology of beclomethasone dipropionate.

Authors:  S E Libretto
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

6.  Hypercatabolism of normal IgG; an unexplained immunoglobulin abnormality in the connective tissue diseases.

Authors:  R D Wochner
Journal:  J Clin Invest       Date:  1970-03       Impact factor: 14.808

7.  Metabolism of human serum albumin in man during acute exposure to high altitude (14,100 feet).

Authors:  M I Surks
Journal:  J Clin Invest       Date:  1966-09       Impact factor: 14.808

8.  Albumin metabolism in rabbits and rats with transplanted tumours.

Authors:  E P Wraight
Journal:  Br J Cancer       Date:  1971-06       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.